MeSH tree: D02.065.950.828
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, according to a study published online ...
Oct 23, 2025
0
13
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group ...
Oct 15, 2025
0
16
Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common drugs for this condition, ...
Sep 25, 2025
0
87
New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of heart-related conditions compared to medications that hit other targets. The study ...
Jul 24, 2025
0
49
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
Jul 1, 2025
0
20
There is increasing interest in finding drugs, known as gerotherapeutics, that can slow aging and help people live longer. Metformin, a common diabetes drug, is being studied because it affects several aging-related processes.
May 20, 2025
0
208
With respect to the proportion of infants born large for gestational age, treatment of gestational diabetes with metformin and glyburide, if needed, does not meet the criteria for noninferiority versus insulin, according ...
Jan 9, 2025
0
20
Almost 500 million adults around the world are living with type 2 diabetes, and over 200 million of those take metformin, an oral medication that reduces blood sugar (glucose) levels. Despite metformin's widespread use, many ...
Aug 28, 2024
0
44
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimize the lifetime risk of diabetes-related complications, including heart attacks, kidney failure ...
May 20, 2024
1
66
An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has revealed the rising use of ...
May 16, 2024
0
33
